Exit

Clinical Approaches to Recognizing and Ma

6/21/2021 Session

Question Title

* 1. Your Name (The instructor will not see your name, used for verification of receipt of evaluation only.)

Question Title

* 2. Email

Question Title

* 3. What was your overall impression of the activity? What went well?

Question Title

* 4. What could have been improved?

Question Title

* 5. What did you learn that was new or different? How and/or will this information change how you practice?

Question Title

* 6. Instruction
A. The program objectives were met. This program was designed to help you:

  strongly disagree disagree neither agree nor disagree agree strongly agree
1) Identify three ways that late-life depression differs from depression in younger adults
2) Identify three risk factors for serious depression in older adults
3) Address suicidal ideation in older adults
4) Distinguish between acute, chronic, and pre-death grief in older adults
B. Accuracy and utility of content were discussed
C. Content was appropriate for postdoctoral level training.
D. Instruction at a level appropriate to postdoctoral training.
E. Teaching methods were effective.
F. Visual aids, handouts & oral presentation clarified content.

Question Title

* 7. Instructor: Susan Laymann, MD

  strongly disagree disagree neither agree nor disagree agree strongly agree
A. Knew the subject matter
B. Presented content effectively (e.g. promoted deep reasoning & learning; including a consideration of obstacles or anomalies)
C. Elaborated upon the stated objectives
D. Maintained my interest
E. Answered questions effectively
F. Was responsive to questions, comments and opinions
G. Provided a variety of applied examples (e.g. cases/vignettes)

Question Title

* 8. Professional and Ethical Issues
A. Sponsoring organization (or presenter) made clearly evident, prior to registration, the following;

  yes no
1) Requirements for successful completion of activity;
2) Accuracy and utility of the materials presented, the basis of such statements, the limitations of the content being taught and the severe and most common risks.
3) Commercial support for CE program, sponsor, or instructor (or any other relationship that could reasonably be construed as a conflict of interest)
4) Commercial support for content instruction (e.g. research grants funding research findings, etc.) that could be construed as a conflict of interest
5) Commercial support or benefit for endorsement of products (e.g books, trainings, drugs, etc.)

T